Assembly Biosciences, Inc. (ASMB): Price and Financial Metrics
ASMB Price/Volume Stats
| Current price | $12.35 | 52-week high | $19.93 |
| Prev. close | $12.24 | 52-week low | $7.75 |
| Day low | $12.20 | Volume | 7,900 |
| Day high | $12.45 | Avg. volume | 27,196 |
| 50-day MA | $10.77 | Dividend yield | N/A |
| 200-day MA | $14.26 | Market Cap | 94.33M |
ASMB Stock Price Chart Interactive Chart >
Assembly Biosciences, Inc. (ASMB) Company Bio
Assembly Biosciences develops oral therapies for intractable infectious diseases in the United States. The company focuses on the hepatitis B virus and C. difficile-associated infections. The company was founded in 2005 and is based in New York, New York.
ASMB Price Returns
| 1-mo | 36.01% |
| 3-mo | -5.94% |
| 6-mo | -26.05% |
| 1-year | -7.84% |
| 3-year | -33.17% |
| 5-year | -94.57% |
| YTD | -21.74% |
| 2024 | 60.35% |
| 2023 | -36.92% |
| 2022 | -44.21% |
| 2021 | -61.49% |
| 2020 | -70.43% |
Continue Researching ASMB
Want to see what other sources are saying about Assembly Biosciences Inc's financials and stock price? Try the links below:Assembly Biosciences Inc (ASMB) Stock Price | Nasdaq
Assembly Biosciences Inc (ASMB) Stock Quote, History and News - Yahoo Finance
Assembly Biosciences Inc (ASMB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...